Fluorescent dye assay for detection of DNA in recombinant protein products

BioTechniques

Volumn 23, Issue 3, 1997, Pages 532-537

  Bolger, R ^b   Lenoch, F ^b   Allen, E ^a   Meiklejohn, B ^a   Burke, T ^b  

^a ELI LILLY AND COMPANY   (United States)

^b INVITROGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; DOUBLE STRANDED DNA; FLUORESCENT DYE; RECOMBINANT PROTEIN; RNA;

ARTICLE; DNA DETERMINATION; FLUORESCENCE;

EID: 0030883766     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/97233pf02     Document Type: Article

References (7)

1. Briggs, J. and P. Panfili. 1991. Quantitation of DNA and protein impurities in biopharmaceuticals. Anal. Chem. 63:850-859.
2. Liu, D., N. Goldman and F. Gates. 1988. Consideration of the proteins and peptides produced by new technology for use as therapeutics, p. 162-171. In Impact of Chemistry on Biotechnology: Multidisciplinary Discussion. ACS Symposium Series 362, American Chemical Society: Washington, DC.
3. Parenteral Drug Association (PDA) Meeting, West Coast Chapter. San Francisco, CA. April 30 - May 3, 1996.
4. Riggin, A. and G. Davis. 1996. Reassessing the control of residual DNA in biopharmaceuticals. Biopharm. 9:36-41.
5. Sambrook, J., E.F. Fritsch and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. CSH Laboratory Press. Cold Spring Harbor, NY.
6. Sanger, F., A. Coulson, T. Friedmann, G. Air, B. Barrell, N. Brown, J. Fiddes, C. Hutchinson, P. Slocombe and M. Smith. 1978. The nucleotide sequence of bacteriophage ΦΧ174. J. Mol. Biol. 125:225-246.
7. WHO Technical Report Series. 1987. Acceptability of Cell Substrates for Production of Biologicals. Report of the Meeting of the Study Group on Biologicals, No. 747.